https://ibsathyroidea.com/wp-content/uploads/2022/10/Hypothyroidism.jpg6071080Thyroidea Staffhttps://ibsathyroidea.com/wp-content/uploads/2021/10/logo_thy_crop.svgThyroidea Staff2022-10-12 06:00:002022-10-20 17:27:50HYPOTHYROIDISM TREATMENT. WHERE ARE WE AND WHERE ARE WE GOING
https://ibsathyroidea.com/wp-content/uploads/2021/07/salvi.png14322548Thyroidea Staffhttps://ibsathyroidea.com/wp-content/uploads/2021/10/logo_thy_crop.svgThyroidea Staff2021-10-13 10:02:052022-05-11 14:37:34CURRENT PROBLEMS IN THE MANAGEMENT OF PATIENTS WITH PRIMARY HYPOTHYROIDISM
https://ibsathyroidea.com/wp-content/uploads/2021/07/trimboli.png14302548Thyroidea Staffhttps://ibsathyroidea.com/wp-content/uploads/2021/10/logo_thy_crop.svgThyroidea Staff2021-04-22 10:00:092022-05-11 14:36:59FEATURES OF DIFFERENT LT4 FORMULATIONS TO REPLACE HYPOTHYROIDISM
https://ibsathyroidea.com/wp-content/uploads/2021/07/the_role.png21543828Thyroidea Staffhttps://ibsathyroidea.com/wp-content/uploads/2021/10/logo_thy_crop.svgThyroidea Staff2021-03-10 14:35:352022-05-11 14:36:42THE ROLE OF SELENIUM IN THE PATHOGENESIS AND TREATMENT OF THYROID DISEASE
https://ibsathyroidea.com/wp-content/uploads/2021/07/different.png21543818Thyroidea Staffhttps://ibsathyroidea.com/wp-content/uploads/2021/10/logo_thy_crop.svgThyroidea Staff2021-01-21 14:18:302022-05-11 14:36:25MANAGEMENT OF DIFFERENTIATED THYROID CANCER PATIENTS FROM INITIAL THERAPY TO 1-YEAR FOLLOW-UP